1211050

GlaxoSmithKline, LLC. — FEI 3004055938

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 20, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Conshohocken, PA (United States)